Smoking-induced changes in nicotine disposition: application of a new HPLC assay for nicotine and its metabolites. 1982

G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell

A sensitive, rapid high-pressure liquid chromatographic assay was developed to compare the disposition of an intravenous dose of 14C-nicotine in normal, carefully matched smokers and nonsmokers. The elimination half-lifes of nicotine and cotinine were shorter in smokers than in nonsmokers. Also consistent with an inductive effect of smoking was the increased nicotine elimination rate constant in smokers, but smoking induced more complex kinetic changes: nicotine volume of distribution was diminished in smokers, whereas nicotine clearance and area under the concentration-time curve were unchanged. The presence of nicotine and its principal metabolites in a morning specimen of urine obtained from nonsmokers before 14C-nicotine administration suggests ubiquitous, passive exposure to and absorption of chemicals present in cigarette smoke.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003367 Cotinine The N-glucuronide conjugate of cotinine is a major urinary metabolite of NICOTINE. It thus serves as a biomarker of exposure to tobacco SMOKING. It has CNS stimulating properties. Scotine
D003497 Cyclic N-Oxides Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen. Heterocyclic N-Oxides,Cyclic N Oxides,Heterocyclic N Oxides,N Oxides, Cyclic,N-Oxides, Cyclic,N-Oxides, Heterocyclic,Oxides, Cyclic N
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits

Related Publications

G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
April 2000, Therapeutic drug monitoring,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
April 1996, Die Pharmazie,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
September 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
February 2008, Biomedical chromatography : BMC,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
October 2002, Journal of pharmaceutical and biomedical analysis,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
August 1987, Journal of chromatography,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
February 1985, British journal of clinical pharmacology,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
September 2000, Annals of clinical biochemistry,
G A Kyerematen, and M D Damiano, and B H Dvorchik, and E S Vesell
November 1973, Biochemistry,
Copied contents to your clipboard!